Dodd, L. E., Korn, E. L., Freidlin, B., Jaffe, C. C., Rubinstein, L. V., Dancey, J., & Mooney, M. M. (2008). Blinded Independent Central Review of Progression-Free Survival in Phase III Clinical Trials: Important Design Element or Unnecessary Expense? American Society of Clinical Oncology.

Dodd, Lori E., Edward L. Korn, Boris Freidlin, C. Carl Jaffe, Lawrence V. Rubinstein, Janet Dancey, ja Margaret M. Mooney. Blinded Independent Central Review of Progression-Free Survival in Phase III Clinical Trials: Important Design Element or Unnecessary Expense? American Society of Clinical Oncology, 2008.

Dodd, Lori E., et al. Blinded Independent Central Review of Progression-Free Survival in Phase III Clinical Trials: Important Design Element or Unnecessary Expense? American Society of Clinical Oncology, 2008.